Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice.

ABSTRACT: We determined risk of virologic failure (VF) in individuals initiating tenofovir/emtricitabine/efavirenz as single versus multiple tablet regimens (MTR). We found no significant difference in the risk of VF, though did observe a trend toward more VF and M184 V mutations among persons initiating MTR. Temporal trends in care may have confounded results.

SUBMITTER: Drozd DR 

PROVIDER: S-EPMC5411186 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature